Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) FCF Margin (2018 - 2025)

Historic FCF Margin for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to 117461.54%.

  • Precision Biosciences' FCF Margin fell 1164283800.0% to 117461.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 10521.35%, marking a year-over-year decrease of 104570100.0%. This contributed to the annual value of 85.44% for FY2024, which is 912000.0% up from last year.
  • Per Precision Biosciences' latest filing, its FCF Margin stood at 117461.54% for Q3 2025, which was down 1164283800.0% from 112627.78% recorded in Q2 2025.
  • Over the past 5 years, Precision Biosciences' FCF Margin peaked at 409.49% during Q1 2021, and registered a low of 117461.54% during Q3 2025.
  • Its 5-year average for FCF Margin is 15916.57%, with a median of 212.07% in 2022.
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 25109900bps in 2021, then crashed by -1164283800bps in 2025.
  • Precision Biosciences' FCF Margin (Quarter) stood at 397.32% in 2021, then surged by 47bps to 212.07% in 2022, then surged by 44bps to 119.31% in 2023, then plummeted by -2367bps to 2943.57% in 2024, then crashed by -3890bps to 117461.54% in 2025.
  • Its FCF Margin stands at 117461.54% for Q3 2025, versus 112627.78% for Q2 2025 and 65917.24% for Q1 2025.